What is Greenwich Lifesciences Inc (GLSI) stock price today?

Greenwich Lifesciences Inc (GLSI) currently trades at $21.60 per share. The stock has a market capitalization of $332.37M and a P/E ratio of —x.

Is GLSI stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Greenwich Lifesciences Inc has a Smart Value Score of 17/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

GLSI

Greenwich Lifesciences Inc

NASDAQ: GLSI · HEALTHCARE · BIOTECHNOLOGY

$21.60

-5.26% today

Updated 2026-04-29

Market cap

$332.37M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.46

Dividend yield

—

52W range

$8 – $34

Volume

0.2M

Market cap

$332.37M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.46

Dividend yield

—

52W range

$8 – $34

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$47.50

+119.91%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-2.67M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-4.57M	$-7.83M	$-8.89M	$-15.79M	$-4.15M
EPS	—	—	—	—	$-1.46
Free cash flow	$-4.29M	$-6.20M	$-6.48M	$-7.27M	$-2.67M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-01-13	PATEL, SNEHAL	Buy	1,800	$29.83
2026-01-12	PATEL, SNEHAL	Buy	2,900	$27.54
2025-12-31	PATEL, SNEHAL	Buy	4,300	$21.36

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GLSI	$332.37M	17	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Greenwich Lifesciences Inc trades at $21.60. Our Smart Value Score of 17/100 indicates the stock is weak.

Frequently asked questions

What is Greenwich Lifesciences Inc's stock price?

Greenwich Lifesciences Inc (GLSI) trades at $21.60.

Is Greenwich Lifesciences Inc overvalued?

Smart Value Score 17/100 (Grade F, Strong Sell).

What is the price target of Greenwich Lifesciences Inc (GLSI)?

The analyst target price is $47.50, representing +119.9% upside from the current price of $21.60.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

greenwichlifesciences.com

Quick metrics

P/S ratio—

ROE-543.00%

Beta1.53

50D MA$25.33

200D MA$16.80

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GLSI vs LLY →GLSI vs JNJ →GLSI vs ABBV →Stock screener →